CardiAI™ is a leading-edge developer of point of Care as shown medical diagnostic technologies. We are developing platform technologies that will transform healthcare worldwide. CardiAI™ prioritizes patient-centric care by communicating and emphasizing patient needs to their health care and information providers. CardiAI™ has a very tenacious R&D team with the capabilities ranging from biomedical engineers, electrochemical engineers, molecular biologists, business development professionals, project managers, clinical managers and clinical trial specialists.The company has developed an electrochemical biosensing based technology platform which it is using to develop point of Care rapid diagnostic tests for Covid-19, Heart failure, and metabolic disorders (such as diabetes) etc. Using AI and machine learning approaches to monitor patient parameters, CardiAI™ anticipates to improve quality of life and reduce healthcare cost.
BPAro
BPAro is a portable ambulatory blood pressure monitor with the most effective and updated health parameters and technology. BPAro can accurately serve as a diagnostic foundation by constantly and dynamically monitoring human blood pressure for a long time or more hours. Patients can use it at home and at a hospital, clinic, or other medical facilities. BPAro has undergone clinical validation for accuracy and has received FDA and Health Canada approval. BPAro automatically monitors and logs patient blood pressure at predetermined intervals. Patients can engage in regular daily activities while using BPAro, including sleeping. BPAro was created and developed to be user-friendly and straightforward to launch. The BPAro app on your computer or mobile device displays all results stored in the user’s personal cloud account.
